Zdrowie i gospodarka · 14/10/1994

FDA Approves Hybritech Inc.'s Tandem-PSA Assays for Premarket Approval

The US Food and Drug Administration (FDA) has granted premarket approval for Hybritech Inc.'s Tandem-PSA assays, following a recommendation from the Immunology Devices Panel, in accordance with the Federal Food, Drug, and Cosmetic Act.